This suppressive action is carried out by TGF-β [23], IL-10 cytokine [52], and CCL2 (MCP-1) [117], which are released by the glioma and microenvironmental cells, which recruits Tregs, MDSC, and TAMs infiltrating the tumor disrupting lymphocyte function. The gene discussed is CCL2; the disease is central nervous system cancer.